MIBG

metaiodobenzylguanidine

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MIBG, covering 2025-04-16 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: MIBG for Refractory Neuroblastoma and Pheochromocytoma [NA]